SHL Stock Overview
Offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Sonic Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$27.97 |
| 52 Week High | AU$32.57 |
| 52 Week Low | AU$23.58 |
| Beta | 0.51 |
| 11 Month Change | 3.02% |
| 3 Month Change | 0.72% |
| 1 Year Change | -2.07% |
| 33 Year Change | -32.76% |
| 5 Year Change | -7.14% |
| Change since IPO | 27,870.00% |
Recent News & Updates
Recent updates
Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 93% Above Its Share Price
Jul 27
These 4 Measures Indicate That Sonic Healthcare (ASX:SHL) Is Using Debt Reasonably Well
Jun 24Sonic Healthcare Limited (ASX:SHL) Investors Are Less Pessimistic Than Expected
May 08Sonic Healthcare's (ASX:SHL) Returns On Capital Not Reflecting Well On The Business
Apr 24Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 90% Above Its Share Price
Mar 07Returns On Capital At Sonic Healthcare (ASX:SHL) Have Hit The Brakes
Dec 26Is Sonic Healthcare Limited (ASX:SHL) Trading At A 46% Discount?
Dec 08Here's Why Sonic Healthcare (ASX:SHL) Can Manage Its Debt Responsibly
Nov 23It's Unlikely That The CEO Of Sonic Healthcare Limited (ASX:SHL) Will See A Huge Pay Rise This Year
Nov 09Returns At Sonic Healthcare (ASX:SHL) Appear To Be Weighed Down
Sep 19Sonic Healthcare (ASX:SHL) Will Pay A Larger Dividend Than Last Year At A$0.62
Sep 02Sonic Healthcare (ASX:SHL) Has Announced That It Will Be Increasing Its Dividend To A$0.62
Aug 19Is Sonic Healthcare Limited (ASX:SHL) Trading At A 31% Discount?
Aug 10Returns Are Gaining Momentum At Sonic Healthcare (ASX:SHL)
May 24Is Sonic Healthcare Limited (ASX:SHL) Trading At A 28% Discount?
May 11We Think Sonic Healthcare (ASX:SHL) Can Stay On Top Of Its Debt
Apr 28Sonic Healthcare's (ASX:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Mar 03We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Feb 17Are Investors Undervaluing Sonic Healthcare Limited (ASX:SHL) By 22%?
Feb 04Here's Why We Think Sonic Healthcare (ASX:SHL) Is Well Worth Watching
Dec 04Here's Why Shareholders May Consider Paying Sonic Healthcare Limited's (ASX:SHL) CEO A Little More
Nov 10Investors Should Be Encouraged By Sonic Healthcare's (ASX:SHL) Returns On Capital
Nov 08Is There An Opportunity With Sonic Healthcare Limited's (ASX:SHL) 36% Undervaluation?
Oct 26Is Sonic Healthcare (ASX:SHL) Using Too Much Debt?
Sep 21Sonic Healthcare (ASX:SHL) Will Pay A Larger Dividend Than Last Year At A$0.60
Aug 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
Aug 24We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Aug 07Sonic Healthcare Limited's (ASX:SHL) Intrinsic Value Is Potentially 62% Above Its Share Price
Jun 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
May 10Shareholders Would Enjoy A Repeat Of Sonic Healthcare's (ASX:SHL) Recent Growth In Returns
Apr 28A Look At The Fair Value Of Sonic Healthcare Limited (ASX:SHL)
Mar 19Sonic Healthcare's (ASX:SHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 23Investors Should Be Encouraged By Sonic Healthcare's (ASX:SHL) Returns On Capital
Jan 22Is Sonic Healthcare (ASX:SHL) Using Too Much Debt?
Dec 26A Look At The Intrinsic Value Of Sonic Healthcare Limited (ASX:SHL)
Dec 14We Like Sonic Healthcare's (ASX:SHL) Returns And Here's How They're Trending
Oct 23With EPS Growth And More, Sonic Healthcare (ASX:SHL) Is Interesting
Oct 12Does Sonic Healthcare (ASX:SHL) Have A Healthy Balance Sheet?
Sep 15Is Sonic Healthcare Limited (ASX:SHL) Worth AU$42.5 Based On Its Intrinsic Value?
Aug 26Does Sonic Healthcare (ASX:SHL) Deserve A Spot On Your Watchlist?
Jul 12Shareholder Returns
| SHL | AU Healthcare | AU Market | |
|---|---|---|---|
| 7D | 8.0% | 1.2% | 0.9% |
| 1Y | -2.1% | 4.3% | 17.7% |
Return vs Industry: SHL underperformed the Australian Healthcare industry which returned 4.3% over the past year.
Return vs Market: SHL underperformed the Australian Market which returned 17.7% over the past year.
Price Volatility
| SHL volatility | |
|---|---|
| SHL Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 8.5% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: SHL has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: SHL's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 42,000 | Colin Goldschmidt | www.sonichealthcare.com |
Sonic Healthcare Limited offers medical diagnostic and administrative services to medical practitioners, hospitals, community health services, and patients in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services.
Sonic Healthcare Limited Fundamentals Summary
| SHL fundamental statistics | |
|---|---|
| Market cap | AU$13.28b |
| Earnings (TTM) | AU$511.09m |
| Revenue (TTM) | AU$8.97b |
26.3x
P/E Ratio1.5x
P/S RatioIs SHL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHL income statement (TTM) | |
|---|---|
| Revenue | AU$8.97b |
| Cost of Revenue | AU$6.02b |
| Gross Profit | AU$2.94b |
| Other Expenses | AU$2.43b |
| Earnings | AU$511.09m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.06 |
| Gross Margin | 32.84% |
| Net Profit Margin | 5.70% |
| Debt/Equity Ratio | 37.0% |
How did SHL perform over the long term?
See historical performance and comparison